艾拉莫德增强丝裂霉素C诱导的人食管癌Eca109细胞凋亡

doi:10.3877/cma.j.issn.2095-1221.2019.01.003

目的

探讨艾拉莫德增强丝裂霉素C（MMC）诱导的人食管癌Eca109细胞凋亡的作用及其机制。

方法

将人食管癌Eca109细胞分为五组：对照组、MMC组、25，50，100 μg/ml浓度艾拉莫德+MMC组；通过CCK-8和DCFH-DA染色法分别检测25，50，100 μg/ml浓度艾拉莫德联合MMC对人食管癌Eca109细胞活力和细胞活性氧（ROS）生成的影响，流式细胞术检测艾拉莫德联合MMC对人食管癌Eca109细胞凋亡的影响，并通过Western Blot检测艾拉莫德联合MMC对TNF-α和cleaved caspase3蛋白表达的影响。采用单因素方差分析和t检验进行统计学分析。

结果

CCK-8结果显示，与0 μg/ml T-614+MMC组A450值（0.85±0.03）比较，25、50、100 μg/ml T-614+MMC组A450值（0.73±0.02，0.52±0.02，0.33±0.02）均降低，差异具有统计学意义（F = 127.60, P < 0.01）；DCFH-DA染色检测结果显示，与0 μg/ml T-614+MMC组DCFH荧光值（130.00±10.00）比较，25、50、100 μg/ml T-614+MMC组DCFH值（219.67±9.50，280.33±10.50，338.33±16.07）均升高，差异具有统计学意义（F = 170.20，P < 0.01）；流式细胞术检测结果显示，与对照组的细胞凋亡率（5.33±0.35）﹪比较，T-614和MMC组的凋亡率（20.30±2.00）﹪，（25.60±3.00）﹪均升高。与MMC组细胞凋亡率（25.60±3.00）﹪比较，艾拉莫德与MMC联用组（T-614+MMC）食管癌Eca109细胞的细胞凋亡率（56.20±3.00）﹪升高，差异均具有统计学意义（F = 247.50，P < 0.01）；Western Blot结果显示，与MMC组细胞TNF-α和cleaved caspase3蛋白表达（0.87±0.06，0.25±0.03）比较，艾拉莫德与MMC联用组（T-614+MMC）食管癌Eca109细胞的TNF-α和cleaved caspase3蛋白表达（1.28±0.08，0.59±0.03）升高，差异均具有统计学意义（F = 96.90，P < 0.01）。

结论

艾拉莫德能够增强MMC对食管癌Eca109细胞活力的抑制作用，其机制可能通过促进ROS的生成，激活线粒体凋亡通路，最终导致食管癌Eca109细胞凋亡。

关键词: 食管癌, 艾拉莫德, 细胞因子, 细胞凋亡, 丝裂霉素

Objective

To investigate the effect of the combination of Iguratimod (T-?614) and mitomycin (MMC) on apoptosis of human esophageal cancer Eca109 cells, and to explore the possible mechanism.

Methods

Eca109 cells were exposed to MMC in the presence or absence of difference concentrations of T-614. Eca109 cell viability and reactive oxygen species (ROS) production were detected by CCK8 and DCFH-DA staining. Apoptosis of Eca109 cells was detected by flow cytometry. Expression of TNFα and cleaved caspase3 in Eca109 cells was detected by Western Blot. Statistical analysis was performed using one-way analysis of variance and t test.

Results

CCK8 results showed that A450 values of 25, 50, and 100 μg/ml T-614+MMC group (0.73±0.02, 0.52±0.02, and 0.33±0.02) were significantly reduced compared with A450 value (0.85±0.03) of 0 μg/?ml T-614+MMC group (F?=?127.60, P?< 0.01) . The results of DCFH-DA staining showed that the DCFH values of the 25, 50, and 100 μg/ml T-614+MMC group (219.67±9.50, 280.33±10.50, and 338.33±16.07) were significantly increased compared with the fluorescence value of DCFH in the 0?μg/ml T-614+MMC group (130.00±10.00) . The difference was statistically significant (F?=?170.20, P?<?0.01) . The results of flow cytometry showed that the apoptosis rate of T-614 group (20.30±2.00) ﹪ and MMC group (25.60±3.00) ﹪ was significantly increased compared with the control group (5.33±0.35) ﹪. Compared with MMC group (25.60±3.00) ﹪, the apoptosis rate (56.20±3.00) ﹪of the T-614+MMC group was significantly increased (F?= 247.50, P?< 0.01) . Western Blot results showed that the expression of TNFα and cleaved caspase3 in T-614+MMC group (1.28±0.08, 0.59±0.03) was significantly increased compared with the expression in MMC group (0.87±0.06, 0.25±0.03) (F?= 96.90, P?< 0.01) .

Conclusion

T-614 significantly enhanced the inhibitory effect of MMC on the viability of Eca109 cells. The mechanism may be related to the production of ROS and the activation of mitochondrial apoptosis pathway, which ultimately leads to apoptosis of esophageal cancer Eca109 cells.

Key words: Esophageal cancer, Iguratimod, Reactive oxygen species, Apoptosis, Mitomycin

表1 不同浓度T-614和T-614+MMC处理后CCK8检测Eca109细胞A450值（ ± s）

T-614分组浓度	样本数	T-614（A450）	T-614+MMC（A450）
0 μg/ml	3	1.05±0.05	0.85±0.03
25 μg/ml	3	0.98±0.08	0.73±0.02^a
50 μg/ml	3	0.82±0.08^a	0.52±0.02^a
100 μg/ml	3	0.55±0.05^a	0.33±0.02^a
F值	?	35.73	127.60
P值	?	< 0.0001	< 0.0001

表1 不同浓度T-614和T-614+MMC处理后CCK8检测Eca109细胞A450值（ ± s）

T-614分组浓度	样本数	T-614（A450）	T-614+MMC（A450）
0 μg/ml	3	1.05±0.05	0.85±0.03
25 μg/ml	3	0.98±0.08	0.73±0.02^a
50 μg/ml	3	0.82±0.08^a	0.52±0.02^a
100 μg/ml	3	0.55±0.05^a	0.33±0.02^a
F值	?	35.73	127.60
P值	?	< 0.0001	< 0.0001

表2 不同浓度T-614和T-614+MMC处理后DCFH法检测Eca109细胞DCFH荧光值（ ± s）

T-614分组浓度	样本数	T-614（DCFH）	T-614+MMC（DCFH）
0 μg/ml	3	35.00± 5.00	130.00±10.00
25 μg/ml	3	41.67± 1.53	219.67± 9.50^a
50 μg/ml	3	90.00±10.00^a	280.33±10.50^a
100 μg/ml	3	136.67±15.28^a	338.33±16.07^a
F值	?	74.71	170.20
P值	?	< 0.0001	< 0.0001

表2 不同浓度T-614和T-614+MMC处理后DCFH法检测Eca109细胞DCFH荧光值（ ± s）

T-614分组浓度	样本数	T-614（DCFH）	T-614+MMC（DCFH）
0 μg/ml	3	35.00± 5.00	130.00±10.00
25 μg/ml	3	41.67± 1.53	219.67± 9.50^a
50 μg/ml	3	90.00±10.00^a	280.33±10.50^a
100 μg/ml	3	136.67±15.28^a	338.33±16.07^a
F值	?	74.71	170.20
P值	?	< 0.0001	< 0.0001

图1 流式细胞术检测艾拉莫德对人食管癌细胞Eca109细胞凋亡的影响

图2 艾拉莫德对人食管癌细胞Eca109细胞凋亡的影响

图3 艾拉莫德对人食管癌细胞Eca109细胞蛋白表达的影响

[1]	Sabra MJ,Smotherman C,Kraemer DF, et al. The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons National surgical quality improvement program (ACS-NSQIP) 2005-2012[J]. J Surg Oncol, 2017, 115(3):296-300.
[2]	Xi M,Liao ZX,Deng WY, et al. Recursive partitioning analysis identifies pretreatment risk groups for the utility of induction chemotherapy before definitive chemoradiation therapy in esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 2017, 99(2):407-416.
[3]	Altorki N,Harrison S. What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?[J]. Ann Cardiothorac Surg, 2017, 6(2):167-174.
[4]	Sun Y,Ye DW,Zhang P, et al. Anti-rheumatic drug iguratimod(T-614)alleviates cancer-induced bone destruction via down-regulating interleukin-6 production in a nuclear factor-kappaB-dependent manner[J]. J Huazhong Univ Sci Technolog Med Sci, 2016, 36(5):691-699.
[5]	Wang ZL,Zhou ZG,Chen Y, et al. Support vector machines model of computed tomography for assessing lymph node metastasis in esophageal cancer with neoadjuvant chemotherapy[J]. J Comput Assist Tomogr, 2017, 41(3):455-460.
[6]	Ku GY. Systemic therapy for esophageal cancer: chemotherapy[J]. Chin Clin Oncol, 2017, 6(5):49.
[7]	Hikami S,Shiozaki A,Fujiwara H, et al. [Outcome of Patients with Pathological Complete Response after Neoadjuvant Chemotherapy in Advanced Esophageal Cancer][J]. Gan To Kagaku Ryoho, 2017, 44(12):1796-1798.
[8]	Fujishima H,Fumoto S,Shibata T, et al. A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer[J]. PLoS One, 2017, 12(11):e0188098.
[9]	Hara M,Abe T,Sugawara S, et al. Long-term safety study of iguratimod in patients with rheumatoid arthritis[J]. Mod Rheumatol, 2007, 17(1):10-16.
[10]	Liu D,Liu CF,Wang N, et al. The research of effects of iguratimod (T- 614) on the apoptosis of peripheral blood mononuclear cell and TH1 in rheumatoid arthritis[J]. Value Health, 2014, 17(7):A772.
[11]	Chen L,Xiong YQ,Xu J, et al. Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction[J]. Oncotarget, 2017, 8(55):93878-93898.
[12]	Wang Y,Yu XY,Song HT, et al. The STAT-ROS cycle extends IFN-induced cancer cell apoptosis[J]. Int J Oncol, 2018, 52(1):305-313.
[13]	Cho HD,Lee JH,Moon KD, et al. Auriculasin-induced ROS causes prostate cancer cell death via induction of apoptosis[J]. Food Chem Toxicol, 2018, 111:660-669.
[14]	Khan F,Khan I,Farooqui A, et al. Carvacrol induces reactive Oxygen species(ROS)-mediated apoptosis along with cell cycle arrest at G0/G1 in human prostate cancer cells[J]. Nutr Cancer, 2017, 69(7):1075-1087.
[15]	Khafaga AF,El-Sayed YS. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression[J]. Naunyn Schmiedebergs Arch Pharmacol, 2018, 391(1):59-70.
[16]	Dyari HRE,Rawling T,Chen Y, et al. A novel synthetic analogue of omega-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells[J]. FASEB J, 2017, 31(12):5246.
[17]	Templin AT,Samarasekera T,Meier DT, et al. Apoptosis repressor with caspase recruitment domain ameliorates Amyloid-Induced beta-Cell apoptosis and JNK pathway activation[J]. Diabetes, 2017, 66(10):2636-2645.
[18]	Mohr A,Deedigan L,Jencz S, et al. Caspase-10: a molecular Switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment[J]. Cell Death Differ, 2018, 25(2):340-352.
[19]	Zhou PP,Wang CL,Hu ZB, et al. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notchl/NF-kappa B/slug/E-cadherin pathway[J]. BMC Cancer, 2017, 17(1):813.
[20]	Zhao Y,Tian B,Wang Y, et al. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5 [J]. Med Sci Monit,2017, 23:5096-5105.
[21]	Thapa B,Bahadur RK,Uludag H. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery[J]. Int J Cancer, 2018, 142(3):597-606.

[1]	钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[2]	孙鸿坤, 艾虹, 陈正. 内质网应激介导的牙周炎骨改建失衡的研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 211-218.
[3]	郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[4]	张燕, 杨跃青, 邱峥. IgG 联合血清细胞因子对肺结核并发慢性肺曲霉菌病的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 809-812.
[5]	傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[6]	黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[7]	季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[8]	阿卜杜萨拉木·图尔荪麦麦提, 吐尔洪江·吐逊, 温浩. 肝脏缺血-再灌注损伤与cGAS-STING信号通路[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 394-397.
[9]	杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[10]	杨智钧, 谷佳, 丁聿贤, 张正奎, 于如同. 脑胶质瘤患者血清炎性因子水平与病理分级及预后的相关性[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 238-242.
[11]	丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[12]	段伟, 刘飞, 许光源, 程宇豪, 陈星. 食管癌调强放疗计划剂量学参数差异对放射性肺炎发生及严重程度的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 320-324.
[13]	陶金华, 陈珊珊, 陈晓四. 阿帕替尼联合替吉奥治疗晚期食管癌的疗效与安全性影响因素评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 325-329.
[14]	高鹏强, 林军鹏, 王佩元, 林辉, 周航, 魏文巍, 柳硕岩, 王枫. 胸段食管鳞状细胞癌中锁骨上淋巴结转移对预后的影响：一项大型回顾性研究[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 211-218.
[15]	李春光, 杨洋, 李斌, 华荣, 李志刚. 完全腹腔镜下管状胃制作技术在食管癌McKeown手术中的应用[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 219-224.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Iguratimod enhances mitomycin C-induced apoptosis in human esophageal cancer Eca109 cells

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Iguratimod enhances mitomycin C-induced apoptosis in human esophageal cancer Eca109 cells